Answers are grounded in this paper and cite their sources.
Cross-sectional study shows 14-3-3η levels associate with TNF-α and MMP-1 in DMARD-naïve rheumatoid arthritis patients, suggesting its potential as a biomarker.
Introduction: 14-3-3η (eta), an intracellular chaperonin, is elevated in the serum of patients with Rheumatoid Arthritis, a progressive inflammatory “autoimmune” disease that impacts joint function and daily activities. This study aimed to assess 14-3-3η levels in DMARD-naïve Rheumatoid Arthritis patients and analyze their association with TNF-α, MMP-1, RA factor, ACCP, and disease activity. Methods: A cross-sectional study was conducted on 90 DMARD-naïve RA patients. The clinical evaluation included the Health Assessment Questionnaire-Disability Index (HAQ-DI) and the Disease Activity Score of 28 joints using ESR (DAS28-ESR). Serum levels of RF, ACCP, 14-3-3η, TNF-α, and MMP-1 were measured using ELISA. Mann-Whitney and Spearman correlation tests were applied, with p < 0.05 considered statistically significant. Results: Among 90 RA patients (76 females, 14 males), 68(75.6%) were seropositive. Serum levels of 14-3-3η and TNF-α differed significantly between seropositive and seronegative groups. TNF- α correlated positively with both 14-3-3η (r = 0.397, p < 0.001) and MMP-1 (r = 0.284, p = 0.007). Discussion: The correlation between 14-3-3η and TNF-α suggests a possible role for 14-3-3η as an adjunctive biomarker in early RA. While findings are promising, the small sample size and lack of follow-up warrant cautious interpretation. Further longitudinal studies are needed to confirm its clinical utility and integration within composite biomarker models. result: Among 90 RA patients(76 female, 14 males), 68(75.6%) were seropositive whereas 22(24.4%) were seronegative. Difference of serum levels of 14-3-3 η and TNF-α between RA groups were statistically significant. Serum TNF-α had a significant positive association with serum 14-3-3 η(r=0.397, p=<.001). Conclusion: Serum 14-3-3η may serve as a supportive biomarker for the diagnosis of early rheumatoid arthritis and assessment of disease activity. Its correlation with TNF-α reflects a potential link to inflammatory burden. Further large-scale, longitudinal studies are needed to confirm its clinical utility.
No takes yet. Share an insight, caveat, or question.
Illahi et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: